Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05319600 · ClinicalTrials.gov registry record · NA
Technology-delivered Physical Activity Program for Adolescents With Type 1 Diabetes
A NA study, sponsored by University of Vermont.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT05319600 is a NA study that has completed, run by University of Vermont. The registered enrollment target is 31 participants.
The verdict
NCT05319600, a NA study, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
This project is comprised of a two-arm randomized control trial (RCT) testing the feasibility, acceptability, and preliminary efficacy of a nationally scalable program, Activate, a 12-week, technology-delivered diabetes behavior-change skills training and physical activity promotion program for adolescents with type 1 diabetes. The researchers have a recruitment goal of 30 participants, but will enroll beyond 30 to address any withdrawal and ensure sample size is met. A primary goal of the study is assessing the feasibility and acceptability of the program, which combines two previously piloted components. Then, the investigators will compare the 12-week Activate program to a treatment as usual control group on proximal outcomes of behavior-change skills and daily active minutes. The investigators will also explore the impact of the Activate program on secondary mechanisms and outcomes linked with later type 1 diabetes health disparities: adolescent diabetes behavior regulation, psychological distress, inflammation, glycemic outcomes, and cardiovascular disease risk. It is hypothesized that a diabetes behavior-change skills training and physical activity intervention will be acceptable, and effective at improving behavior-change skills and daily active minutes, as well as other mechanisms and outcomes linked with later type 1 diabetes health disparities.
Interventions
- BEHAVIORAL Diabetes behavior change skills training
- BEHAVIORAL Physical activity promotion program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2022-04-18 |
| Est. Completion | 2024-03-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05319600
The ClinicalTrials.gov registry entry for NCT05319600 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Diabetes behavior change skills training is the first listed.
NCT05319600 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05319600 about?
NCT05319600 is a clinical study titled "Technology-delivered Physical Activity Program for Adolescents With Type 1 Diabetes". This project is comprised of a two-arm randomized control trial (RCT) testing the feasibility, acceptability, and preliminary efficacy of a nationally scalable program, Activate, a 12-week, technology-delivered diabetes behavior-change skills training and physical activity promotion program for adol...
What is the current status of trial NCT05319600?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2022-04-18. Estimated completion is 2024-03-21.
What interventions are being tested in trial NCT05319600?
The interventions under investigation include: Diabetes behavior change skills training (BEHAVIORAL), Physical activity promotion program (BEHAVIORAL).
Who is sponsoring clinical trial NCT05319600?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.